The broad objective of the project is to clarify the role of D1-like dopamine receptors in the pathophysiology of schizophrenia.
The specific aim i s to further develop and apply PET scan procedures for quantitative radioligand studies on D1-like dopamine receptors in all areas of the human living brain. This methodology will be applied to replicate and further develop the investigator's preliminary finding of reduced D1 dopamine receptor binding in brain regions of drug-naive schizophrenic patients. For the PET scanning procedure the new high affinity and relatively selective D1 dopamine receptor antagonist (11C)NNC 112 will be used. The investigators's preliminary results have demonstrated that this ligand has a higher ratio of specific to nonspecific binding and other advantages as compared to the investigator's previously developed radioligand (11C)SCH 23390. This allows the quantification of D1-densities in a number of limbic and neocortical regions besides the basal ganglia in living healthy and schizophrenic subjects. The second specific aim is to systematically combine the PET approach with human postmortem brain studies. Whole hemispheres from control and schizophrenic subjects will be cryosectioned in extenso to provide up to 1 500 hemisphere sections from each brain. These consecutive sections will allow the development of comprehensive detailed quantitative maps of D1 dopamine receptor binding in all regions of the human brain using (3H) NNC 112. This postmortem material will also be processed in parallel to explore the quantitative distribution of the gene messages for D1 and D5 dopamine receptors and related proteins throughout the human brain by in situ hybridization histochemistry. The PET scan experiments will be performed using the investigator's new 3D acquisition Siemens ECAT HR 47 PET camera system allowing the resolution of structures in the living human brain down to the order of about 3-4 mm. For the postmortem studies autoradiographic image information will be retrieved by a high resolution video camera system allowing the quantification and visualization of D1 dopamine receptor characteristics in all areas of brain of human subjects down to a resolution of about 50 microns. The complete sets of image data from PET and postmortem analyses will be stored and processed by means of fast high capacity computer media (Silicon Graphics) for the construction of the first rapidly accessible quantitative 3D information banks concerning D1-like dopamine receptor characteristics throughout the brain of individual healthy and schizophrenic human subjects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH044814-13
Application #
6391944
Study Section
Clinical Neuroscience and Biological Psychopathology Review Committee (CNBP)
Program Officer
Meinecke, Douglas L
Project Start
1989-02-01
Project End
2002-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
13
Fiscal Year
2001
Total Cost
$166,577
Indirect Cost
Name
Karolinska Institute
Department
Type
DUNS #
350582235
City
Stockholm
State
Country
Sweden
Zip Code
171 7-7
Varnas, Katarina; Hurd, Yasmin L; Hall, Hakan (2005) Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse 56:21-8
Varnas, Katarina; Halldin, Christer; Hall, Hakan (2004) Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22:246-60
Varnas, Katarina; Thomas, David R; Tupala, Erkki et al. (2004) Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci Lett 367:313-6
Jonsson, Erik G; Abou Jamra, Rami; Schumacher, Johannes et al. (2003) No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia. Psychiatr Genet 13:175-8
Varnas, Katarina; Halldin, Christer; Pike, Victor W et al. (2003) Distribution of 5-HT4 receptors in the postmortem human brain--an autoradiographic study using [125I]SB 207710. Eur Neuropsychopharmacol 13:228-34
Jonsson, Erik G; Flyckt, Lena; Burgert, Edgar et al. (2003) Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatr Genet 13:1-12
Jonsson, Erik G; Sillen, Anna; Vares, Maria et al. (2003) Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am J Med Genet B Neuropsychiatr Genet 119B:28-34
Okugawa, Gaku; Sedvall, Goran C; Agartz, Ingrid (2003) Smaller cerebellar vermis but not hemisphere volumes in patients with chronic schizophrenia. Am J Psychiatry 160:1614-7
Damberg, Mattias; Berggard, Cecilia; Mattila-Evenden, Marja et al. (2003) Transcription factor AP-2beta genotype associated with anxiety-related personality traits in women. A replication study. Neuropsychobiology 48:169-75
Pike, Victor W; Halldin, Christer; Nobuhara, Kenji et al. (2003) Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET. Eur J Nucl Med Mol Imaging 30:1520-8

Showing the most recent 10 out of 67 publications